Neural Regeneration Research, 2017 · DOI: 10.4103/1673-5374.200810 · Published: February 1, 2017
This study investigates the potential of Tanshinone IIA (TIIA), a compound from Salvia miltiorrhiza Bunge, to improve lower urinary tract (LUT) function after spinal cord injury (SCI) in rats. Rats with SCI were treated with TIIA, and their bladder function, spinal cord regeneration, and nerve cell health were compared to those treated with methylprednisolone (MP), a standard treatment, and a control group. The findings suggest that TIIA can improve bladder function and promote spinal cord regeneration, potentially offering a new treatment approach for SCI-induced LUT dysfunction.
Tanshinone IIA may serve as a potential therapeutic agent for SCI-induced LUT dysfunction.
TIIA could be an alternative to methylprednisolone with potentially fewer side effects.
TIIA has great potential in remodeling the spinal pathway related to LUT control.